As part of our ongoing mission to support the development of treatments for the five primary subtypes of congenital muscular dystrophy, Cure CMD has committed $375k in research grant funding for 2026-2028

Ashley Burkman shares how testifying for Medicaid highlighted the daily reality of CMD caregiving and how honest storytelling can drive advocacy and change.

Researchers at the University of Basel are developing a gene therapy that could potentially treat those living with LAMA2-Related Dystrophy.